[ Back to EurekAlert! ]

Contact: Juliette Savin
pr@riken.jp
81-048-462-1225
RIKEN

Retinal Pigment Epithelium Cells Derived From Human iPS Cells

Caption: RIKEN announces the launch of a pilot study to assess the safety and feasibility of the transplantation of autologous induced pluripotent stem cell-derived retinal pigment epithelium cell sheets in patients with exudative (wet-type) age-related macular degeneration.

Credit: RIKEN

Usage Restrictions: None

Related news release: Pilot clinical study into iPS cell therapy for eye disease starts in Japan


[ Back to EurekAlert! ]